These observations open up the possibility that chronic blockade of either ROS, RAAS or the resulting inducible nitric oxide synthase (iNOS) in the PVN may prevent end organ damage in hypertension or Type-2 CRS. This evidence concerns the gene NOS2 and Hypertension.